Skip to search.
 BSE Down1.93% NSE Down2.09%

Supernus Pharmaceuticals, Inc. (SUPN)

-NasdaqGM

6.61 Up 0.01(0.15%) 1:29AM|After Hours : 6.53 Down 0.12 (1.80%) 1:31AM - Nasdaq Real Time Price

Add to Portfolio
Industry: Drugs - GenericGet Industry for:
SUPN Sector / Industry Membership
Sector:Healthcare
Industry:Drugs - Generic
Intraday Performance Summary
NameTickerChange
Chart for Supernus Pharmaceuticals, Inc. (SUPN)
Supernus Pharmaceuticals, Inc.SUPNUp0.15%

Top Drugs - Generic Companies by Market Cap
CompanySymbolPriceChangeMarket CapP/E
Dr. Reddy Laboratories, Ltd.DRREDDY.NS2,051.45Down0.21%348.42B20.84
Dr. Reddy Laboratories, Ltd.DRREDDY.BO2,051.05Down0.27%348.35B20.84
Hikma Pharmaceuticals plcHIK.L970.00Down1.27%1.91B1,917.00
Divi's Laboratories Ltd.DIVISLAB.BO980.30Down1.44%130.12B24.39
Divi's Laboratories Ltd.DIVISLAB.NS979.70Down1.54%130.04B24.38
Supernus Pharmaceuticals, Inc.SUPN6.60Up0.15%204.08MN/A
SUPN vs. Industry Leaders
StatisticIndustry LeaderSUPNSUPN Rank
Market CapitalizationDRREDDY.NS348.42B204.08M48 / 74
P/E Ratio (ttm)HIK.L1,917.00N/AN/A
PEG Ratio (ttm, 5 yr expected)LGND3.28N/AN/A
Revenue Growth (Qtrly YoY)QRX.AX527.80%-29.30%N/A
EPS Growth (Qtrly YoY)AHLCONQ.BO153.70%N/AN/A
Long-Term Growth Rate (5 yr)AVNR56.00%N/AN/A
Return on Equity (ttm)DIVISLAB.BO27.15%-266.79%46 / 74
Long-Term Debt/Equity (mrq)48.730N/A
Dividend Yield (annual)N/AN/A

Currency in USD.